Sodium salt (5S,6R)-3-tert-butyl-6-hydroxymethyl-7-oxo-4-oxa-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate

ID: ALA69067

PubChem CID: 44310661

Max Phase: Preclinical

Molecular Formula: C11H14NNaO5

Molecular Weight: 241.24

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)C1=C(C(=O)[O-])N2C(=O)[C@H](CO)[C@@H]2O1.[Na+]

Standard InChI:  InChI=1S/C11H15NO5.Na/c1-11(2,3)7-6(10(15)16)12-8(14)5(4-13)9(12)17-7;/h5,9,13H,4H2,1-3H3,(H,15,16);/q;+1/p-1/t5-,9-;/m0./s1

Standard InChI Key:  SMXZLUQMLSNJAH-WFZUHFMFSA-M

Molfile:  

     RDKit          2D

 19 19  0  0  0  0  0  0  0  0999 V2000
    4.7042   -8.3167    0.0000 Na  0  0  0  0  0 15  0  0  0  0  0  0
    5.2542   -6.7292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0417   -6.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2542   -5.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4292   -6.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5167   -6.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4292   -5.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0292   -5.6542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2917   -7.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3417   -6.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8417   -7.3167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7917   -8.4917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1042   -7.9417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8417   -5.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0542   -4.5292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7167   -7.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4167   -5.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1167   -6.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0916   -4.9300    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  1  0
  4  2  1  0
  5  2  1  0
  6  3  2  0
  7  5  1  0
  4  8  1  0
  9  3  1  0
 10  6  1  0
 11  5  2  0
 12  9  1  0
 13  9  2  0
  7 14  1  6
 15 14  1  0
 16 10  1  0
 17 10  1  0
 18 10  1  0
  7  4  1  0
  8  6  1  0
  4 19  1  1
M  CHG  2   1   1  12  -1
M  END

Associated Targets(non-human)

blaZ Beta-lactamase (285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Beta-lactamase (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 241.24Molecular Weight (Monoisotopic): 241.0950AlogP: 0.14#Rotatable Bonds: 2
Polar Surface Area: 87.07Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 4.05CX Basic pKa: CX LogP: -0.37CX LogD: -3.50
Aromatic Rings: Heavy Atoms: 17QED Weighted: 0.67Np Likeness Score: 0.90

References

1. Wild H, Metzger K.  (1993)  Substituted 6-alkyloxapenems: potent -lactamase inhibitors: synthesis and biological characterization,  (11): [10.1016/S0960-894X(01)80926-4]

Source